Mycotoxins

Haschek and Rousseaux's Handbook of Toxicologic Pathology

Volumn , Issue , 2013, Pages 1187-1258

  Haschek, Wanda M ^a   Voss, Kenneth A ^b  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

Aflatoxin B1; Aflatoxins; Deoxynivalenol (DON); Diacetoxyscirpenol (DAS); Ergot alkaloids; Fescue toxicosis; Fumonisin B1; Fumonisins; HT 2 toxin; Macrocyclic trichothecenes; Mycotoxins; Ochratoxin A; Satratoxin G; T 2 toxin; Trichothecenes; Zearalenone

Indexed keywords

EID: 84883983407     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-415759-0.00039-X     Document Type: Chapter

References (217)

1. Berthiller F., Crews C., Dall'asta C., Saeger S.D., Haesaert G., Karlovsky P., Oswald I.P., Seefelder W., Speijers G., Stroka J. Masked mycotoxins: A Review. Mol. Nutr. Food Res. 2013, 57:165-186.
2. Bhat R.V., Shetty P.H., Amruth R.P., Sudershan R.V. A foodborne disease outbreak due to the consumption of moldy sorghum and maize containing fumonisin mycotoxins. J. Toxicol. Clin. Toxicol. 1997, 35:249-255.
3. Bondy G.S., Pestka J.J. Immunomodulation by fungal toxins. J. Toxicol. Environ. Health B, Crit. Rev. 2000, 3:109-143.
4. Bryden W.L. Mycotoxin contamination of the feed supply chain: implications for animal productivity and feed security. Anim. Feed Sci. Technol. 2012, 173:134-158.
5. CAST Task Force Report 139 Mycotoxins: Risks in Plant, Animal, and Human Systems 2003, Council for Agricultural Science and Technology, Ames, IA, 2003.
6. Eaton D.L., Beima K.M., Bammler T.K., Riley R.T., Voss K.A. Hepatotoxic mycotoxins. Comprehensive Toxicology 2010, vol. 10:527-569. Elsevier, New York, NY. second ed. R.A. Roth, P.E. Ganey (Eds.).
7. IARC-WHO Some naturally occurring substances: Food items and constituents, heterocyclic aromatic amines and mycotoxins. IARC. Monographs on the Evaluation of Carcinogenic Risks to Humans 1993, 56:467-488.
8. Jestoi M. Emerging fusarium-mycotoxins, fusaproliferin, beauvericin, enniatins, and moniliformin: a review. Crit. Rev. Food. Sci. Nutr. 2008, 48:21-49.
9. Köppen R., Koch M., Siegel D., Merkel S., Maul R., Nehls I. Determination of mycotoxins in foods: current state of analytical methods and limitations. Appl. Microbiol. Biotechnol. 2010, 86:1595-1612.
10. Kuiper-Goodman T. Food safety: mycotoxins and phycotoxins in perspective. Mycotoxins and Phycotoxins - Developments in Chemistry, Toxicology, and Food Safety 1998, 25-48. Fort Collins, Alaken Inc., CO. M. Miraglia, H. van Egmond, C. Brera, J. Gilbert (Eds.).
11. Leung M.C., Díaz-Llano G., Smith T.K. Mycotoxins in pet food: a review on worldwide prevalence and preventative strategies. J. Agric. Food. Chem. 2006, 54:9623-9635.
12. Matossian M.A.K. Poisons of the Past: Molds: Epidemics and History 1989, Yale University Press, New Haven, CT.
13. Meggs W.J. Epidemics of mold poisoning: past and present. Toxicol. Ind. Health 2009, 25:571-576.
14. Richard J.L. Some major mycotoxins and their mycotoxicoses - an overview. Int. J. Food Microbiol. 2007, 119:3-10.
15. Riley R.T., Voss K.A. Developing mechanism-based and exposure biomarkers for mycotoxins in animals. Determining Mycotoxins and Mycotoxigenic Fungi in Food and Feed 2011, 245-278. Ghent University, Woodhead Publishing Limited, Cambridge, UK. S. De Saeger (Ed.).
16. Scudamore K.A., Hetmanski M.T., Nawaz S., Naylor J., Rainbird S. Determination of mycotoxins in pet foods sold for domestic pets and wild birds using linked-column immunoassay clean-up and HPLC. Food Addit. Contam. 1997, 14:175-186.
17. Snyman L.D., Kellerman T.S., Vleggaar R., Flett B.C., Basson K.M., Schultz R.A. Diplonine, a neurotoxin isolated from cultures of the fungus Stenocarpella maydis (Berk.) Sacc. that induces diplodiosis. J. Agric. Food Chem. 2011, 59:9039-9044.
18. Turner P.C., Flannery B., Isitt C., Ali M., Pestka J. The role of biomarkers in evaluating human health concerns from fungal contaminants in food. Nutr. Res. Rev. 2012, 25:162-179.
19. World Health Organization (WHO) Selected Mycotoxins: Ochratoxins, Trichothecenes, Ergot. Environmental Health Criteria; 105, United Nations Environmental Programme 1990, International Labour Organization and the World Health Organization, Geneva.
20. Wild C.P., Gong Y.Y. Mycotoxins and human disease: a largely ignored global health issue. Carcinogenesis 2010, 31:71-82.
21. Azziz-Baumgartner E., Lindblade K., Gieseker K., Rogers H.S., Kieszak S., Njapau H., Schleicher R., McCoy L.F., Misore A., DeCock K., Rubin C., Slutsker L. Aflatoxin Investigative Group. Case-control study of an acute aflatoxicosis outbreak, Kenya, 2004. Environ. Health. Perspect. 2005, 113:1779-1783. Erratum in: Environ. Health Perspect. (2006). 114, A90.
22. Caloni F., Cortinovis C. Toxicological effects of aflatoxins in horses. Vet. J. 2011, 188:270-273.
23. Coppock R.W., Christian R.R.G., Jacobsen B.J. Aflatoxins. Veterinary Toxicology 2012, 1181-1191. Elsevier, New York, NY. second ed. R.C. Gupta (Ed.).
24. Dereszynski D.M., Center S.A., Randolph J.F., Brooks M.B., Hadden A.G., Palyada K.S., McDonough S.P., Messick J., Stokol T., Bischoff K.L., Gluckman S., Sanders S.Y. Clinical and clinicopathological features of dogs that consumed foodborne hepatotoxic aflatoxins: 72 cases (2005-2006). J. Am. Vet. Med. Assoc. 2008, 232:1329-1337.
25. El-Serag H.B. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 2012, 142:1264-1273.
26. Gouas D., Shi H., Hainaut P. The aflatoxin-induced TP53 mutation at codon 249 (R249S): biomarker of exposure, early detection and target for therapy. Cancer Lett. 2009, 286:29-37.
27. 1. Toxicology 2012, 299:69-79.
28. Hoerr F.J., D'Andrea G.H., Giambrone J.J., Panangala V.S. Comparative histopathologic changes in aflatoxicosis. Diagnosis of Mycotoxicoses 1986, 179-189. Martin Nijhoff Publishers, Boston, MA. J.L. Richard, J.R. Thurston (Eds.).
29. 1 albumin adduct levels and cellular immune status in Ghanaians. Int. Immunol. 2005, 17:807-814.
30. 1-albumin adduct levels in HIV-positive Ghanaians. Food Addit. Contam. Part A Chem. Anal. Control. Expo. Risk. Assess. 2011, 28:1224-1234.
31. Kensler T.W., Egner P.A., Wang J.B., Zhu Y.R., Zhang B.C., Lu P.X., Chen J.G., Qian G.S., Kuang S.Y., Jackson P.S., Gange S.J., Jacobson L.P., Muñoz A., Groopman J.D. Chemopreventation of hepatocellular carcinoma in aflatoxin endemic areas. Gestroenterology 2004, 127:S310-S318.
32. Kensler T.W., Roebuck B.D., Wogan G.N., Groopman J.D. Aflatoxin: a 50-year odyssey of mechanistic and translational toxicology. Toxicol. Sci. 2011, 120(S1):S28-S48.
33. Khlangwiset P., Shephard G.S., Wu F. Aflatoxins and growth impairment: a review. Crit. Rev. Toxicol. 2011, 41:740-755.
34. Liu Y., Wu F. Global burden of aflatoxin-induced hepatocellular carcinoma: a risk assessment. Environ. Health Perspect. 2010, 118:818-824.
35. Liu Y., Chang C.C., March G.M., Wu F. Population attributable risk of aflatoxin-related liver cancer: systematic review and meta-analysis. Eur. J. Cancer 2012, 48:2125-2136.
36. Liu Y., Wu F. Global burden of aflatoxin-induced hepatocellular carcinoma: a risk assessment. Environ. Health Perspect. 2010, 118:818-824.
37. Miller D.M., Crowell W.A., Stuart B.P. Acute aflatoxicosis in swine: clinical pathology, histopathology, and electron microscopy. Am. J. Vet. Res. 1982, 43:273-277.
38. Newberne P.M., Butler W.H. Acute and chronic effects of aflatoxin on the liver of domestic and laboratory animals: a review. Cancer Res. 1969, 29:236-250.
39. 1 carcinogenesis in the rat. Cancer Res. 1968, 28:770-781.
40. Newman S.J., Smith J.R., Stanske K.A., Newman L.B., Dunlap J.R., Imerman P.M., Kirk C.A. Aflatoxicosis in nine dogs after exposure to contaminated commercial dog food. J. Vet. Diag. Invest. 2007, 19:168-175.
41. 1 in poultry: toxicology, metabolism and prevention. Res. Vet. Sci. 2010, 89:325-331.
42. 1 biomarker blood levels in pregnant women in Kumasi, Ghana. Trop. Med. Int. Health 2010, 15:160-167.
43. Stenske K.A., Smith J.R., Newman S.J., Newman L.B., Kirk C.A. Aflatoxicosis in dogs and dealing with suspected contaminated commercial foods. J. Am. Vet. Med. Assoc. 2006, 228:1686-1691.
44. 1. Hepatology 1999, 30:379-383.
45. Turner P.C., Moore S.E., Hall A.J., Prentice A.M., Wild P.C. Modification of immune function through exposure to dietary aflatoxin in Gambian children. Environ. Health Perspect. 2003, 111:217-220.
46. Turner P.C., Collinson A.C., Cheung Y.B., Gong Y., Hall A.J., Prentice A.M., Wild P.C. Aflatoxin exposure in utero causes growth faltering in Gambian infants. Int. J. Epidemiol. 2007, 36:1119-1125.
47. Villar S., Ortiz-Cuaran S., Abedi-Ardekani B., Gouas D., Nogueira da Costa A., Plymoth A., Khuhaprema T., Kalalak A., Sangrajrang S., Friesen M.D., Groopman J.D., Hainaut P. Aflatoxin-induced TP53 R249S mutation in hepatocellular carcinoma in Thailand: association with tumors developing in the absence of liver cirrhosis. PLoS One 2012, 7:e37707.
48. Wild C.P., Montesano R. A model of interaction: aflatoxin and hepatitis viruses in cancer aetiology and prevention. Cancer Lett. 2009, 286:22-28.
49. Williams D.E. The rainbow trout liver cancer model: response to environmental chemicals and studies on promotion and chemoprevention. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 2012, 155:121-127.
50. Williams J.H., Phillips T.D., Jolly P.E., Stiles J.K., Jolly C.M., Aggarwal A. Human aflatoxicosis in developing countries: a review of toxicology, exposure, potential health consequences, and interventions. Am. J. Clin. Nutr. 2004, 80. 1106-1022.
51. Wogan G.N., Kensler T.W., Goopman J.D. Present and future directions of translational research on aflatoxin and hepatocellular carcinoma: a review. Food Addit. Contam. Part A Chem. Anal. Control Expo. Risk Assess. 2012, 29:249-257.
52. 1-DNA adduct formation and mutagenicity in livers of neonatal male and female B6C3Fi mice. Toxicol. Sci. 2011, 122:38-44. Erratum in Toxicol. Sci. (2012) 125, 326.
53. Wu F., Khlangwiset P. Evaluating the technical feasibility of aflatoxin risk reduction strategies in Africa. Food Addit. Contam. Part A Chem. Anal. Control Expo. Risk Assess. 2010, 27:658-676.
54. Anzai N., Jutabha P., Endou H. Molecular mechanism of ochratoxin A transport in the kidney. Toxins 2010, 2:1381-1398.
55. Babu E., Takeda M., Narikawa S., Kobayashi Y., Enomoto A., Tojo A., Cha S.H., Sekine T., Sakthisekaran D., Endou H. Role of human organic anion transporter 4 in the transport of ochratoxin A. Biochim. Biophys. Acta. 2002, 1590:64-75.
56. Bend J., Bolger M., Knaap A.G., Kuznesof P.M., Larsen J.C., Mattia A., Meylan I., Pitt J.I., Resnik S., Schlatter J., Vavasour E., Rao M.V., Verger P., Walker R., Wallin H., Whitehouse B., Abbott P.J., Adegoke G., Baan R., Baines J., Barlow S., Bendord D., Bruno A., Charrondiere R., Chem J., Choi M., DiNovi M., Fisher C.E., Iseki N., Sawamura Y., Konishi Y., Lawrie S., Leblanc J.C., Leclercq C., Lee H.M., Moy G., Munro I.C., Nishikawa A., Olempska-Beer Z., De Peuter G., Pronk M.E., Renwidk A.G., Sheffer M., Sipes I.G., Tritscher A., Soares L.V., Wennberg A., Williams G.M. Ochratoxin A. Evaluation of Certain Food Additives and Contaminants: Sixty-eighth Report of the Joint FAO/WHO Expert Committee on Food Additives 2007, 169-180. WHO Technical Report Series 947, World Health Organization, Geneva, Switzerland.
57. 1 mouse. J. Natl. Cancer Inst. 1985, 75:733-742.
58. Benford D., Boyle C., Dekant D., Fuchs R., Gaylor D.W., Hard G., McGregor D.B., Pitt J.I., Plestina R., Shephard G., Solfrizzo M., Verger P.J.P., Walker R. Ochratoxin A. Safety Evaluation of Certain Mycotoxins in Food 2001, 281-415. WHO Food Additives Series 47, FAO Nutrition Paper 74, Geneva, Switzerland.
59. Boorman G.A., McDonald M.R., Imoto S., Persing R. Renal lesions induced by ochratoxin A exposure in the F344 rat. Toxicol. Pathol. 1992, 20:236-245.
60. Carlton W.W., Tuite J. Comparative pathologic changes in ochratoxicosis and citrinin toxicosis. Diagnosis of Mycotoxicoses 1986, 195-204. Martin Nijhoff Publishers, Boston, MA. J.L. Richard, J.R. Thurston (Eds.).
61. Castegnaro M., Mohr U., Pfohl-Leszkowicz A., Estève J., Steinmann J., Tillman T., Michelon J., Bartsch H. Sex- and strain-specific induction of renal tumors by ochratoxin A in rats correlates with DNA adduction. Int. J. Cancer 1998, 77:70-75.
62. Cook W.O., Osweiler G.D., Anderson T.D., Richard J.L. Ochratoxicosis in Iowa swine. J. Am. Vet. Med. Assoc. 1986, 188:1399-1402.
63. Endemic Nephropathy in Croatia 1996, Academia Croatica Scientiarum Medicarum, Zagreb, Croatia. D. Cvorišcec, S. Ceovic, A. Stavljenic-Rukavina (Eds.).
64. Czakai K., Müller K., Mosesso P., Pepe G., Schulze M., Gohla A., Patnaik D., Dekant W., Higgins J.M., Mally A. Perturbation of mitosis through inhibition of histone acetyltransferases: the key to ochratoxin A toxicity and carcinogenicity?. Toxicol. Sci. 2011, 122:319-329.
65. De Broe M.E. Chinese herbs nephropathy and Balkan endemic nephropathy: toward a single entity, aristolochic acid nephropathy. Kidney Int. 2012, 81:513-515.
66. Delatour T., Mally A., Richoz J., Ozden S., Dekant W., Ihmels H., Otto D., Gasparutto D., Marin-Kaun M., Schilter B., Calvin C. Absence of 2'-deoxyguanosin-carbon 8-bound ochratoxin A adduct in rat kidney DNA monitored by isotope dilution LC-MS/MS. Mol. Nutr. Food Res. 2008, 52:472-482.
67. Duarte S.C., Lino C.M., Pena A. Ochratoxin A in feed of food-producing animals: an undesirable mycotoxin with health and performance effects. Vet. Microbiol. 2011, 154:1-13.
68. European Food Safety Authority Panel on Contaminants in the Food Chain (CONTAM) Statement on recent scientific information on the toxicity of Ochratoxin A, 2010 European Food Safety Authority Panel on Contaminants in the Food Chain (CONTAM) Statement on recent scientific information on the toxicity of Ochratoxin A. (2010) EFSA. Journal 8, 1626 [7 pp]. Available at, (last accessed 10/2012). http://www.efsa.europa.eu/efsajournal.
69. Gekle M., Silbernagl S. Renal toxicodynamics of ochratoxin A: a pathophysiological approach. Kidney Blood Press. Res. 1996, 19:225-235.
70. Gekle M., Sauvant C., Schwerdt G., Silbernagl S. Tubulotoxic mechanisms of ochratoxin A. Kidney Blood Press. Res. 1998, 21:277-279.
71. Gupta R.C. Ochratoxins and citrinin. Veterinary Toxicology 2012, 1220-1226. Elsevier, New York, NY. second ed. R.C. Gupta (Ed.).
72. Haighton L.A., Lynch B.S., Magnuson B.A., Nestmann E.R. A reassessment of risk associated with dietary intake of ochratoxin A based on a lifetime exposure model. Crit. Rev. Toxicol. 2012, 42:147-168.
73. Hibi D., Suzuki Y., Ishii Y., Jin M., Watanabe M., Sugita-Konishi Y., Yanai T., Nohmi T., Nishikawa A., Umemura T. Site-specific in vivo mutagenicity in the kidney of gpt delta rats given a carcinogenic dose of ochratoxin A. Toxicol. Sci. 2011, 122:406-414.
74. Jelaković B., Karanović S., Vuković-Lela I., Miller F., Edwards K.L., Nikolić J., Tomić K., Slade N., Brdar B., Turesky R.J., Stipančić Ž, Dittrich D., Grollman A.P., Dickman K.G. Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid. Kidney Int. 2012, 81:559-567.
75. Jung K.Y., Takeda M., Kim D.K., Tojo A., Narikawa S., Yoo B.S., Hosoyamada M., Cha S.H., Sekine T., Endou H. Characterization of ochratoxin A transport by human organic anion transporters. Life Sci. 2001, 21:2123-2135.
76. Kozaczynski W. Experimental ochratoxicosis A in chickens. Histopathological and histochemical study. Arch. Vet. Pol. 1994, 34:205-219.
77. Kuiper-Goodman T., Hilts C., Billiard S.M., Kiparissis Y., Richard I.D.K., Hayward S. Health risk assessment of ochratoxin A for all age-sex strata in a market economy. Food Addit. Contam. Part A. Chem. Anal. Control Expo. Risk Assess. 2010, 27:212-240.
78. Mally A. Ochratoxin A and mitotic disruption: mode of action analysis of renal tumor formation by ochratoxin A. Toxicol. Sci. 2012, 127:315-330.
79. Mally A., Dekant W. Mycotoxins and the kidney: modes of action for renal tumor formation by ochratoxin A in rodents. Mol. Nutr. Food Res. 2009, 53:467-478.
80. Mantle P.G., Kulinskaya E. Lifetime, low-dose ochratoxin A dietary study on renal carcinogenesis in male Fischer rats. Food Addit. Contam. Part A. Chem. Anal. Control Expo. Risk Assess. 2010, 27:1566-1573.
81. Mantle P.G., Faucet-Marquis V., Manderville R.A., Squillaci B., Pfohl-Leszkowicz A. Structures of covalent adducts between DNA and ochratoxin A: a new factor in the debate about genotoxicity and human risk assessment. Chem. Res. Toxicol. 2010, 23:89-98.
82. National Toxicology Program Technical Report on the Toxicology and Carcinogenesis Studies of Ochratoxin A (Case No 303-47-9) in F344 N Rats. NTP Technical Report No. 358. US Department of Health and Human Services 1989, National Institutes of Health, Research Triangle Park, NC. G. Boorman (Ed.).
83. Pepeljnjak S., Klarić M.Š "Suspects" in etiology of endemic nephropathy: aristolochic acid versus mycotoxins. Toxins (Basel) 2010, 2:1414-1427.
84. Peraica M., Domijan A.-M., Šarić M. Mycotoxin and aristolochic acid theories of the development of endemic nephropathy. Arh. Hig. Rada Toksikol. 2008, 59:59-65.
85. Pfohl-Leszkowicz A., Manderville R.A. An update on direct genotoxicity as a molecular mechanism of ochratoxin A carcinogenicity. Chem. Res. Toxicol. 2011, 25:252-262.
86. Rached E., Hard G.C., Blumbach K., Weber K., Draheim R., Lutz W.K., Ozden S., Steger U., Dekant W., Mally A. Ochratoxin A: 13-week oral toxicity and cell proliferation in male F344 rats. Toxicol. Sci. 2007, 97:288-298.
87. Stoev S.D., Hald B., Mantle P.G. Porcine nephropathy in Bulgaria: a progressive syndrome of complex or uncertain (mycotoxin) aetiology. Vet. Rec. 1998, 142:190-194.
88. Szczech G.M., Carlton W.W., Tuite J. Ochratoxicosis in beagle dogs. II Pathology. Vet. Pathol. 1973, 10:219-231.
89. Szczech G.M., Carlton W.W., Tuite J., Caldwell R. Ochratoxin A toxicosis in swine. Vet. Pathol. 1973, 16:466-475.
90. Wei X., Sulik K.K. Pathogenesis of craniofacial and body wall malformations induced by ochratoxin A in mice. Am. J. Med. Genet. 1993, 47:862-871.
91. Wu Q., Dohnal V., Huang L., Kuča K., Wang X., Chen G., Yuan Z. Metabolic pathways of ochratoxin A. Curr. Drug. Metab. 2011, 12:1-10.
92. Zlender V., Breljak D., Ljubojević M., Flajs D., Baleln D., Brzica H., Domijan A.M., Peraica M., Fuchs R., Anzai N., Sabolić I. Low doses of ochratoxin A upregulate the protein expression of organic anion transporters Oat1, Oat2, Oat3 and Oat5 in rat kidney cortex. Toxicol. Appl. Pharmacol. 2009, 239:284-296.
93. Trichothecene Mycotoxicosis: Pathophysiologic Effects 1989, CRC Press, Boca Raton, FL. V.R. Beasley (Ed.).
94. Cresia D.A., Lambert R.J. Acute respiratory tract toxicity of the trichothecene mycotoxin, T-2 toxin. Trichothecene Mycotoxicosis: Pathophysiological Effects 1989, vol. 1:161-170. CRC Press, Inc., Boca Raton, FL. V.R. Beasley (Ed.).
95. Haschek W.M., Beasley V.R. Trichothecene mycotoxins. Handbook of Toxicology of Chemical Warfare Agents 2009, 353-369. Academic Press, Elsevier, San Diego, CA. R.C. Gupta (Ed.).
96. McCormick S.P., Stanley A.M., Stover N.A., Alexander N.J. Trichothecenes: from simple to complex mycotoxins. Toxins (Basel) 2011, 3(7):802-814.
97. Mostrom M.S., Raisbeck M.F. Trichothecenes. Veterinary Toxicology 2012, 1239-1265. Academic Press, San Diego, CA. second ed. R.C. Gupta (Ed.).
98. Schollenberger M., Drochner W., Müller H.M. Fusarium toxins of the scirpentriol subgroup: a review. Mycopathologia 2007, 164(3):101-118.
99. Sudakin D.L. Trichothecenes in the environment: relevance to human health. Toxicol. Lett. 2003, 143:97-107.
100. Trenholm H.L., Friend D., Hamilton R.M.G., Prelusky D.B., Foster B.C. Lethal toxicity and nonspecific effects. Trichothecene Mycotoxicosis: Pathophysiological Effects 1989, vol. 1:161-170. CRC Press, Inc., Boca Raton, FL. V.R. Beasley (Ed.).
101. Ueno Y. The toxicology of mycotoxins. Crit. Rev. Toxicol. 1985, 14(2):99-132.
102. Wu Q., Dohnal V., Huang L., Kuca K., Yuan Z. Metabolic pathways of trichothecenes. Drug. Metab. Rev. 2010, 42:250-267.
103. Charmley E., Trenholm H.L., Thompson B.K., Vudathala D., Nicholson J.W.G., Prelusky D.B., Charmley L.L. Influence of level of deoxynivalenol in the diet of dairy cows on feed intake, milk production, and its composition. J. Dairy Sci. 1993, 76:3580-3587.
104. Opinion of the Scientific Panel on Contaminants in the Food Chain on the request from the Commision related to Deoxynivalenol (DON) as an undesirable substance in animal feed. EFSA J 2004, 73:1-42. European Food Safety Authority Panel on Contaminants in the Food Chain (CONTAM), 2004 European Food Safety Authority Panel on Contaminants in the Food Chain (CONTAM), Updated 2007. Available at, (last accessed 10/2012). http://www.efsa.europa.eu/efsajournal.
105. Flannery B.M., Wu W., Pestka J.J. Characterization of deoxynivalenol-induced anorexia using mouse bioassay. Food Chem. Toxicol. 2011, 49:1863-1869.
106. Flannery B.M., Clark E.S., Pestka J.J. Anorexia induction by the trichothecene deoxynivalenol (vomitoxin) is mediated by the release of the gut satiety hormone peptide YY (PYY). Toxicol. Sci. 2012, 130:289-297.
107. Girardet C., Bonnet M.S., Jdir R., Sadoud M., Thirion S., Tardivel C., Roux J., Lebrun B., Wanaverbecq N., Mounien L., Trouslard J., Jean A., Dallaporta M., Troadec J.D. The food-contaminant deoxynivalenol modifies eating by targeting anorexigenic neurocircuitry. PLoS One 2011, 6:e26134.
108. Iverson F., Armstrong C., Nera E., Truelove J., Fernie S., Scott P., Stapley R., Hayward S., Gunner S. Chronic feeding study of deoxynivalenol in B6C3F1 male and female mice. Teratog. Carcinog. Mutagen. 1995, 15:283-306.
109. Mikami O., Kubo M., Murata H., Muneta Y., Nakajima Y., Miyazaki S., Tanimura N., Katsuda K. The effects of acute exposure to deoxynivalenol on some inflammatory parameters in miniature pigs. J. Vet. Med. Sci. 2011, 73:665-671.
110. Pestka J.J. Deoxynivalenol-induced IgA production and IgA nephropathy-aberrant mucosal immune response with systemic repercussions. Toxicol. Lett. 2003, 11:140-141.
111. Pestka J.J. Deoxynivalenol: mechanisms of action, human exposure, and toxicological relevance. Arch. Toxicol. 2010, 84:663-679.
112. Pestka J.J. Deoxynivalenol-induced proinflammatory gene expression: mechanisms and pathological sequelae. Toxins (Basel) 2010, 2:1300-1317.
113. Pinton P., Tsybulskyy D., Lucioli J., Laffitte J., Callu P., Lyazhri F., Grosjean F., Bracarense A.P., Kolf-Clauw M., Oswald I.P. Toxicity of deoxynivalenol and its acetylated derivatives on the intestine: differential effects on morphology, barrier function, tight junctions proteins and MAP kinases. Toxicol. Sci. 2012, 130:180-190.
114. Turner P.C., Hopton R.P., White K.L., Fisher J., Cade J.E., Wild C.P. Assessment of deoxynivalenol metabolite profiles in UK adults. Food Chem. Toxicol. 2011, 49:132-135.
115. World Health Organization (WHO) Evaluation of certain contaminants in food. WHO Tech. Rep. Ser. 2011, 959:1-105.
116. Yunus A.W., Blajet-Kosicka A., Kosicki R., Khan M.Z., Rehman H., Böhm J. Deoxynivalenol as a contaminant of broiler feed: intestinal development, absorptive functionality, and metabolism of the mycotoxin. Poultry. Sci. 2012, 91:52-61.
117. Zielonka Ł, Wiśniewska M., Gajecka M., Obremski K., Gajecki M. Influence of low doses of deoxynivalenol on histopathology of selected organs of pigs. Pol. J. Vet. Sci. 2009, 12:89-95.
118. Scientific opinion on the risks for animal and public health related to the presence of T-2 and HT-2 toxin in food and feed. EFSA J 2011, 9. European Food Safety Authority Panel on Contaminants in the Food Chain (CONTAM), 2418 [187 pages]. Available at, (last accessed 10/2012). http://www.efsa.europa.eu/efsajournal.
119. Ihara T., Sugamata M., Sekijima M., Okumura H., Yoshino N., Ueno Y. Apoptotic cellular damage in mice after T-2 toxin-induced acute toxicosis. Nat. Toxins 1997, 5:141-145.
120. Joffe A.Z. Food borne diseases: Alimentary toxic aleukia. CRC Handbook of Food-borne Diseases of Biological Origin 1983, 353-495. CRC Press, Boca Raton, FL. M. Recheigl (Ed.).
121. Li Y., Wang Z., Beier R.C., Shen J., De Smet D., De Saeger S., Zhang S. T-2 toxin, a trichothecene mycotoxin: review of toxicity, metabolism, and analytical methods. J. Agric. Food Chem. 2011, 59:3441-3453.
122. Pang V.F., Adams J.H., Beasley V.R., Buck W.B., Haschek W.M. Myocardial and pancreatic lesions induced by T-2 toxin, a trichothecene mycotoxin, in swine. Vet. Pathol. 1986, 23:310-319.
123. Ravindran J., Agrawal M., Gupta N., Rao P.V. Alteration of blood brain barrier permeability by T-2 toxin: Role of MMP-9 and inflammatory cytokines. Toxicology 2011, 280:44-52.
124. Wang L.H., Fu Y., Shi Y.X., Wang W.G. T-2 toxin induces degenerative articular changes in rodents: link to Kaschin-Beck disease. Toxicol. Pathol. 2011, 39:502-507.
125. Yang J.Y., Zhang Y.F., Liang A.M., Kong X.F., Li Y.X., Ma K.W., Jing A.H., Feng S.Y., Qiao X.L. Toxic effects of T-2 toxin on reproductive system in male mice. Toxicol. Ind. Health 2010, 26:25-31.
126. Andersson M.A., Nikulin M., Koljalg U., Andersson M.C., Rainey F., Reijula K., Hintikka E.L., Salkinoja-Salonen M. Bacteria, molds, and toxins in water-damaged building materials. Appl. Environ. Microbiol. 1997, 63:387-393.
127. Carey S.A., Plopper C.G., Hyde D.M., Islam Z., Pestka J.J., Harkema J.R. Satratoxin-G from the black mold Stachybotrys chartarum induces rhinitis and apoptosis of olfactory sensory neurons in the nasal airways of rhesus monkeys. Toxicol. Pathol. 2012, 40:887-898.
128. Corps K.N., Islam Z., Pestka J.J., Harkema J.R. Neurotoxic, inflammatory, and mucosecretory responses in the nasal airways of mice repeatedly exposed to the macrocyclic trichothecene mycotoxin roridin A: dose-response and persistence of injury. Toxicol. Pathol. 2010, 38:429-451.
129. Institute of Medicine Damp Indoor Spaces and Health. C. o. D. I. S. a. Health 2004, Institute of Medicine of the National Academies, Washington, DC, (last accessed 10/2012). http://ntp.niehs.nih.gov/ntp/htdocs/chem_background/exsumpdf/stachybotry s.pdf.
130. Islam Z., Harkema J.R., Pestka J.J. Satratoxin G from the black mold Stachybotrys chartarum evokes olfactory sensory neuron loss and inflammation in the murine nose and brain. Environ. Health Perspect. 2006, 114:1099-1107.
131. Jarvis B.B., Miller J.D. Mycotoxins as harmful indoor air contaminants. Appl. Microbiol. Biotechnol. 2005, 66:367-372.
132. Johanning E., Biagini R., Hull D., Morey P., Jarvis B., Landsbergis P. Health and immunology study following exposure to toxigenic fungi (Stachybotrys chartarum) in water-damaged office environment. Int. Arch. Occup. Environ. Health 1996, 68:207-218.
133. Lichtenstein J.H., Molina R.M., Donaghey T.C., Amuzie C.J., Pestka J.J., Coull B.A., Brain J.D. Pulmonary responses to Stachybotrys chartarum and its toxins: mouse strain affects clearance and macrophage cytotoxicity. Toxicol. Sci. 2010, 116:113-121.
134. Mahmoudi M., Gershwin M.E. Sick building syndrome. III. Stachybotrys chartarum. J. Asthma 2000, 37:191-198.
135. Pestka J.J., Yike I., Dearborn D.G., Ward M.D., Harkema J.R. Stachybotrys chartarum, trichothecene mycotoxins, and damp building-related illness: new insights into a public health enigma. Toxicol. Sci. 2008, 104:4-26.
136. Strauss D.C. The possible role of fungal contamination in sick building syndrome. Front. Biosci. Elite Ed. 2011, 3:562-580.
137. Tuomi T., Reijula K., Johnsson T., Hemminki K., Hintikka E.L., Lindroos O., Kalso S., Koukila-Kahkola P., Mussalo-Rauhamaa H., Haahtela T. Mycotoxins in crude building materials from water-damaged buildings. Appl. Environ. Microbiol. 2000, 66:1899-1904.
138. Thrasher J.D., Gray M.R., Kilburn K.H., Dennis D.P., Yu A. A water-damaged home and health of occupants: a case study. J. Environ. Public. Health 2012, 2012:312836.
139. Bandera E.V., Chandran U., Buckley B., Lin Y., Isukapalli S., Marshall I., King M., Zarbl H. Urinary mycoestrogens, body size and breast development in New Jersey girls. Sci. Total. Environ. 2011, 409:5221-5227.
140. Belli P., Bellaton C., Durand J., Balleydier S., Milhau N., Mure M., Mornex J.F., Benahmed M., Le Jan C. Fetal and neonatal exposure to the mycotoxin zearalenone induces phenotypic alterations in adult rat mammary gland. Food Chem. Toxicol. 2010, 48:2818-2826.
141. Biehl M.L., Prelusky D.B., Koritz G.D., Hartin K.E., Buck W.B., Trenholm H.L. Biliary excretion and enterohepatic cycling of zearalenone in immature pigs. Toxicol. Appl. Pharmacol. 1993, 121:152-159.
142. Collins T.F., Sprando R.L., Black T.N., Olejnik N., Eppley R.M., Alam H.Z., Rorie J., Ruggles D.I. Effects of zearalenone on in utero development in rats. Food Chem. Toxicol. 2006, 44:1455-1465.
143. Dai S., Duan J., Lu Y., Zhang Y., Cheng J., Ren J., Zhao X., Wu Y., Yu Y., Zuo P., Wu Y., Ge Q. Phytoestrogen alph-ZEA ralanol inhibits atherogenesis and improves lipid profile in ovariectomized cholesterol-fed rabbits. Endocrine 2004, 25:121-129.
144. Dänicke S., Swiech E., Buraczewska L., Ueberschär K.H. Kinetics and metabolism of zearalenone in young female pigs. J. Anim. Physiol. Anim. Nutr. (Berl.) 2005, 89:268-276.
145. Scientific Opinion on the risks for public health related to the presence of zearalenone in food. EFSA J 2011, 9. European Food Safety Authority Panel on Contaminants in the Food Chain (CONTAM), 2197 [124 pp.]. Available at, (last accessed 10/2012). http://www.efsa.europa.eu/de/efsajournal/doc/2197.pdf.
146. European Food Safety Authority Opinion of the Scientific Panel on Contaminants in the Food Chain on a request from the Commission related to zearalenone as undesirable substance in animal feed. EFSA J. 2004, 89:1-35.
147. Fugh-Berman A. "Bust enhancing" herbal products. Obstet. Gynecol. 2003, 101:1345-1349.
148. Gajecka M., Janowski T., Jakimiuk E., Polak M., Podhalicz-Dziegielewska M., Rotkiewicz T., Otrocka-Domagała I., Obremski K., Zielonka L., Gajecki M. Histopathological and immunohistochemical examinations, and changes in proliferation activity of the uterus in bitches following zearalenon micotoxicosis. Pol. J. Vet. Sci. 2007, 10:143-151.
149. Gajecka M., Obremski K., Jakimiuk E., Skorska-Wyszyńska E., Zielonka L., Gajecki M. Histopathological examination of ovaries in bitches after experimental zearalenone mycotoxicosis. Pol. J. Vet. Sci. 2008, 11:363-366.
150. Gajecka M., Rybarczyk L., Zwierzchowski W., Jakimiuk E., Zielonka L., Obremski K., Gajecki M. The effect of experimental, long-term exposure to low-dose zearalenone mycotoxicosis on the histological condition of ovaries in sexually immature gilts. Theriogenology 2011, 75:1085-1094.
151. Gajecka M., Rybarczyk L., Jakimiuk E., Zielonka Ł, Obremski K., Zwierzchowski W., Gajecki M. The effect of experimental long-term exposure to low-dose zearalenone on uterine histology in sexually immature gilts. Exp. Toxicol. Pathol. 2012, 64:537-542.
152. Haschek W.M., Haliburton J.C. Diagnosis of Mycotoxicoses. Fusarium moniliforme and zearalenone toxicoses in domestic animals: a review 1986, 213-235. Martin Nijhoff Publishers, Boston, MA. J.L. Richard, J.R. Thurston (Eds.).
153. Jefferson W.N., Padilla-Banks E., Clark G., Newbold R.R. Assessing estrogenic activity of phytochemicals using transcriptional activation and immature mouse uterotrophic responses. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 2002, 777:179-189.
154. Jiang S.Z., Yang Z.B., Yang W.R., Gao J., Liu F.X., Broomhead J., Chi F. Effects of purified zearalenone on growth performance, organ size, serum metabolites, and oxidative stress in postweaning gilts. J. Anim. Sci. 2011, 89:3008-3015.
155. Kuiper-Goodman T., Scott P.M., Watanabe H. Risk assessment of the mycotoxin zearalenone. Regul. Toxicol. Pharmacol. 1987, 7:253-306.
156. Li Y., Burns K.A., Arao Y., Luh C.J., Korach K.S. Differential
157. Liu S., Lin Y.C. Transformation of MCF-10A human breast epithelial cells by zeranol and estradiol-17beta. Breast J. 2004, 10:514-521.
158. Mantovani A., Frazzoli C., La Rocca C. Risk assessment of endocrine-active compounds in feeds. Vet. J. 2009, 182:392-401.
159. Massart F., Saggese G. Oestrogenic mycotoxin exposures and precocious pubertal development. Int. J. Androl. 2010, 33:369-376.
160. Mostrom M.S. Zearalenone. Veterinary Toxicology 2012, 1266-1271. Academic Press, San Diego, CA. second ed. R.C. Gupta (Ed.).
161. Nikaido Y., Danbara N., Tsujita-Kyutoku M., Yuri T., Uehara N., Tsubura A. Effects of prepubertal exposure to xenoestrogen on development of estrogen target organs in female CD-1 mice. In. Vivo 2005, 19:487-494.
162. National Toxicology Program Carcinogenicity bioassay of zearalenone in F344/N rats and F6C3F1 mice. National Toxicology Program Technical Reports Series 1982, 235. National Toxicology Program. NC: Research Triangle Park.
163. Pazaiti A., Kontos M., Fentiman I.S. ZEN and the art of breast health maintenance. Int. J. Clin. Pract. 2012, 66:28-36.
164. Schoevers E.J., Santos R.R., Colenbrander B., Fink-Gremmels J., Roelen B.A. Transgenerational toxicity of zearalenone in pigs. Reprod. Toxicol. 2012, 34:110-119.
165. World Health Organization (WHO) Zearalenone. Prepared by the Fifty-third meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA). Safety Evaluation of Certain Food Additives and Contaminants. WHO Food Additives Series 44 2000, International Programme on Chemical Safety, WHO, Geneva, Switzerland.
166. Yuri T., Nikaido Y., Shimano N., Uehara N., Shikata N., Tsubura A. Effects of prepubertal zeranol exposure on estrogen target organs and N-methyl-N-nitrosourea-induced mammary tumourigenesis in female Sprague-Dawley rats. In Vivo 2004, 18:755-761.
167. Yuri T., Tsukamoto R., Miki K., Uehara N., Matsuoka Y., Tsubura A. Biphasic effects of zeranol on the growth of estrogen receptor-positive human breast carcinoma cells. Oncol. Rep. 2006, 16:1307-1312.
168. Zinedine A., Soriano J.M., Moltó J.C., Mañes J. Review on the toxicity, occurrence, metabolism, detoxification, regulations and intake of zearalenone: an oestrogenic mycotoxin. Food Chem. Toxicol. 2007, 45:1-18.
169. International conference on the toxicology of fumonisin Environ Health Perspect 2001, 109:237-342. (Suppl. 2). W.T. Allaben, J.R. Bucher, P.C. Howard (Eds.).
170. 1) mycotoxin in a solid rice culture infected with Fusarium verticillioides by reversed-phase high-performance liquid chromatography/electron spray ionization time-of-flight and ion trap mass spectrometry. Rapid. Commun. Mass. Spectrom. 2010, 24:35-42.
171. Bolger M., Coker R.D., DiNovi M., Gaylor D., Gelderblom W., Olsen M., Paster N., Riley R.T., Shephard G., Speijers G.J.A. Fumonisins. Safety Evaluation of Certain Mycotoxins in Foods 2001, FAO Food and Nutrition Paper 74, World Health Organization, Geneva, Switzerland, 103-279.
172. Bulder A.S., Arcella D., Bolger M., Carrington C., Kpodo K., Resnik S., Riley R.T., Wolterink G., Wu F. Fumonisins (addendum). Safety Evaluation of Certain Food Additives and Contaminants 2012, 325-794. WHO Food Additives Series 65, World Health Organization, Geneva, Switzerland.
173. Dall'Asta C., Mangia M., Berthiller F., Molinelli A., Sulyok M., Schumacher R., Krska R., Galaverna G., Dossena A., Marchelli R. Difficulties in fumonisin determination: the issue of hidden fumonisins. Anal. Bioanal. Chem. 2009, 395:1335-1345.
174. Dall'Asta C., Falavigna C., Galaverna G., Dossena A., Marchelli R. In vitro digestion assay for determination of hidden fumonisins in maize. J. Agric. Food Chem. 2010, 58:12042-12047.
175. 1 as an example. Toxicol. Sci. 2001, 61:6-17.
176. 1 intravenously. Am. J. Vet. Med. 2004, 8:223-230.
177. 1 in rats. Carcinogenesis 1991, 12:1247-1251.
178. Gelineau-van Waes J.B., Voss K.A., Stevens V.L., Speer M.C., Riley R.T. Maternal fumonisin exposure as a risk factor for neural tube defects. Adv. Food Nutr. Res. 2009, 56:145-181.
179. Gumprecht L.A., Beasley V.R., Weigel R.M., Parker H.M., Tumbleson M.E., Bacon C.W., Meredith F.I., Haschek W.M. Development of fumonisin-induced hepatotoxicity and pulmonary edema in orally dosed swine: morphological and biochemical alterations. Toxicol. Pathol. 1998, 26:777-788.
180. 1, a toxic metabolite of Fusarium moniliforme. J. Vet. Diagn. Invest. 1990, 2:217-221.
181. 1 includes rare variants of renal tubular tumor. Toxicol. Pathol. 2002, 29:379-386.
182. Hsiao S.H., Constable P.D., Tumbleson M.E., Haschek W.M. Use of formalin-fixed tissues to determine fumonisin B1 induced sphingolipid alterations in swine. J. Vet. Diag. Invest. 2007, 19:425-430.
183. Humpf H.-U., Voss K.A. Effects of food processing on the chemical structure and toxicity of fumonisin mycotoxins. Mol. Nutr. Food Res. 2004, 48:255-269.
184. 1. Onderstepoort. J. Vet. Res. 1990, 57:269-275.
185. Ledoux D.R., Brown T.P., Weibking T.S., Rottinghaus G.E. Fumonisin toxicity in broiler chicks. J. Vet. Diag. Invest. 1992, 4:330-333.
186. 1 and moniliformin on performance and selected immune parameters in turkey poults. Poult. Sci. 2000, 79:871-878.
187. Marasas W.F.O., Riley R.T., Hendricks K.A., Stevens V.L., Sadler T.W., Gelineau-van Waes J., Missmer S.A., Cabrera J., Torres O., Gelderblom W.C.A., Allegood J., Martínez C., Maddox J., Miller J.D., Starr L., Sullards M.C., Roman A.V., Voss K.A., Wang E., Merrill A.H. Fumonisins disrupt sphingolipid metabolism, folate transport and development of neural crest cells in embryo culture and in vivo: A potential risk factor for human neural tube defects among populations consuming fumonisin-contaminated maize. J. Nutr. 2004, 134:711-716.
188. Rheeder J.P., Marasas W.F.O., Vismer H.F. Production of fumonisin analogs by Fusarium species. Appl. Environ. Microbiol. 2002, 68:2101-2105.
189. Riley R.T., Voss K.A. Differential sensitivity of rat kidney and liver to fumonisin toxicity: Organ specific differences in toxin accumulation and sphingoid base metabolism. Toxicol. Sci. 2006, 92:335-345.
190. Shephard G.S., Marasas W.F., Burger H.M., Somdyala N.I., Rheeder J.P., van der Westhuizen L., Gatyeni P., van Schalkwyk D.J. Exposure assessment for fumonisins in the former Transkei region of South Africa. Food Addit. Contam. 2007, 24:621-629.
191. Smith G.W. Fumonisins. Veterinary Toxicology 2012, 1205-1219. Academic Press, Elsevier, San Diego, CA. second ed. R.C. Gupta (Ed.).
192. Smith G.W., Constable P.D., Bacon C.W., Meredith F.I., Haschek W.M. Cardiovascular effects of fumonisins in swine. Fundam. Appl. Toxicol. 1996, 31:169-172.
193. 1 decreases cardiovascular function but does not alter pulmonary capillary permeability in swine. Toxicol. Sci. 2000, 56:240-249.
194. 1 in ducks and after exposure to a diet containing the maximum European tolerance for fumonisins in avian feeds. Chem. Biol. Interact. 2009, 182:239-244.
195. van der Westhuizen L., Shephard G.S., Rheeder J.P., Somdyala N.I., Marasas W.F. Sphingoid base levels in humans consuming fumonisin-contaminated maize in rural areas of the former Transkei, South Africa: a cross-sectional study. Food Addit. Contam. Part A Chem. Anal. Control Expo. Risk Assess. 2008, 25:1385-1391.
196. Voss K.A., Riley R.T., Jackson L.S., Jablonski J.E., Bianchini A., Bullerman L.B., Hanna M.A., Ryu D. Extrusion cooking with glucose supplementation of fumonisin-contaminated corn grits protects against nephrotoxicity and disrupted sphingolipid metabolism in rats. Mol. Nutr. Food. Res. 2011, 55:S312-S320. Erratum in: Mol. Nutr. Food Res. 55, 1597.
197. Voss K.A., Smith G.W., Haschek W.M. Fumonisins: toxicokinetics, mechanism of action and toxicity. Anim. Feed Sci. Technol. 2007, 137:299-325.
198. Belser-Ehrlich S., Harper A.R., Hussey J., Hallock R.M. Human and cattle ergotism since 1900: Symptoms, outbreaks, and regulations. Toxicol. Ind. Health 2012, [Epub ahead of print].
199. Elenkova A., Shabani R., Kalinov K., Zacharieva S. Increased prevalence of subclinical cardiac valve fibrosis in patients with prolactinomas on long-term bromocriptine and cabergoline treatment. Eur. J. Endocrinol. 2012, 167:17-25.
200. Scientific opinion on ergot alkaloids in food and feed. EFSA J 2012, 10. European Food Safety Authority Panel on Contaminants in the Food Chain (CONTAM), 2798 [158 pp.]. Available at. http://www.efsa.europa.eu/de/efsajournal/pub/2798.pdf.
201. Krska R., Crews C. Significance, chemistry and determination of ergot alkaloids: a review. Food Addit. Contam. Part A Chem. Anal. Control Expo. Risk Assess. 2008, 25:722-731.
202. Newman L.C., Lipton R.B. Ergot alkaloids. Experimental and Clinical Neurotoxicology 2000, 535-537. Oxford University Press, Oxford, UK. second ed. P.S. Spencer, H.H. Schaumberg, A.L. Ludolph (Eds.).
203. Strickland J.R., Looper M.L., Matthews J.C., Rosenkrans C.F., Flythe M.D., Brown K.R. Board-invited review: St. Anthony's Fire in livestock: causes, mechanisms, and potential solutions. J. Anim. Sci. 2011, 89:1603-1626.
204. Naudè T.W., Botha C.J., Vorster J.H., Roux C., Van der Linde E.J., Van der Walt S.I., Rottinghaus G.E., Van Jaarsveld L., Lawrence A.N. Claviceps cyperi, a new cause of severe ergotism in dairy cattle consuming maize silage and teff hay contaminated with ergotised Cyperus esculentus (nut sedge) on the Highveld of South Africa. Onderstepoort. J. Vet. Res. 2005, 72:23-37.
205. Nicholson S.S. Ergot. Veterinary Toxicology 2012, 1200-1204. Academic Press, San Diego, CA. second ed. R.C. Gupta (Ed.).
206. Ross A.D., Bryden W.L., Bakau W., Burgess L.W. Induction of heat stress in beef cattle by feeding the ergots of. Claviceps pupurea. Aust. Vet. J. 1989, 66:247-249.
207. Boosinger T.R., Brendemuehl J.P., Bransby D.L., Wright J.C., Kemppainen R.J., Kee D.D. Prolonged gestation, decreased triiodothyronine concentration, and thyroid gland histomorphologic features in newborn foals of mares grazing Acremonion coenophialum-infected fescue. Am. J. Vet. Res. 1995, 56:66-69.
208. Evans T.J. The endocrine disruptive effects of ergopeptine alkaloids on pregnant mares. Vet. Clin. North. Am. Equine. Pract. 2011, 27:165-173.
209. Evans T.J., Blodgett D.J., Rottinghaus G.E. Fescue toxicosis. Veterinary Toxicology 2012, 1166-1180. Academic Press, San Diego, CA. second ed. R.C. Gupta (Ed.).
210. Johnstone L.K., Mayhew I.G., Fletcher L.R. Clinical expression of lolitrem B (perennial ryegrass) intoxication in horses. Equine. Vet. J. 2012, 44:304-309.
211. Poppenga R.H., Mostrom M.S., Haschek W.M., Lock T.F., Buck W.B., Beasley V.R. Mare agalactia, placental thickening, and high foal mortality associated with the grazing of tall fescue. A case report. Am. Assoc. Vet. Lab. Diagn. 27th Annu. Proc. 1984, 325-336.
212. Putnam M.R., Bransby D.I., Schumacher J., Boosinger T.R., Bush L., Shelby R.A., Vaughan J.T., Ball D., Brendemuehl J.P. Effects of the fungal endophyte Acremonium coenophialum in fescue on pregnant mares and foal viability. Am. J. Vet. Res. 1991, 52:2071-2074.
213. Riet-Correa F., Mendez M.C., Schild A.L., Bergamo P.N., Flores W.N. Agalactica, reproductive problems and neonatal mortality in horses associated with the ingestion of. Claviceps purpurea. Aust. Vet. J. 1988, 65:192-193.
214. Roberts C.A., Spiers D.E., Karr A.L., Benedict H.R., Sleper D.A., Eichen P.A., West C.P., Piper E.L., Rottinghaus G.E. Use of a rat model to evaluate tall fescue seed infected with introduced strains of. Neotyphodium coenophialum. J. Agric. Food Chem. 2002, 50:5742-5745.
215. Settivari R.S., Evans T.J., Rucker E., Rottinghaus G.E., Spiers D.E. Effect of ergot alkaloids associated with fescue toxicosis on hepatic cytochrome P450 and antioxidant proteins. Toxicol. Appl. Pharmacol. 2008, 227:347-356.
216. Stamm M.M., DelCurto T., Horney M.R., Brandyberry S.D., Barton R.K. Influence of alkaloid concentration of tall fescue straw on the nutrition, physiology and subsequent performance of beef steers. J. Anim. Sci. 1994, 72:1068-1075.
217. Tor-Agbidye J., Blythe L.L., Craig A.M. Correlation of endophyte toxins (ergovaline and lolitrem B) with clinical disease: fescue foot and perennial ryegrass staggers. Vet. Hum. Toxicol. 2001, 43:140-146.